Assessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis.

ABSTRACT:

Main problem

Chronic kidney disease (CKD) is a progressive condition that affects millions of people worldwide. A standardized core outcome set (COS) was developed for CKD by the International Consortium for Health Outcomes and Measurements in 2019. This study aims to evaluate the frequency of measurement for these outcomes before and after the publication of the COS.

Methods

A literature search was done to gather the phase III/IV clinical trials evaluating chronic kidney disease through ClinicalTrials.gov. Data extraction of included studies was completed in a masked, duplicate fashion. The included studies were evaluated for characteristics such as survival, burden of disease, patient-reported health-related quality of life, and treatment modality-specific outcomes.

Res

SUBMITTER: Hagood A 

PROVIDER: S-EPMC11387250 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature